Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 4—April 2012
Dispatch

Human Parvovirus 4 Infection, Cameroon

Myriam Lavoie, Colin P. Sharp, Jacques PépinComments to Author , Christopher Pennington, Yacouba Foupouapouognigni, Oliver G. Pybus, Richard Njouom, and Peter Simmonds
Author affiliations: Université de Sherbrooke, Sherbrooke, Quebec, Canada (M. Lavoie, J. Pépin); University of Edinburgh, Edinburgh, Scotland, UK (C.P. Sharp, C. Pennington, P. Simmonds); Centre Pasteur du Cameroun, Yaoundé, Cameroon (Y. Foupouapouognigni, R. Njouom); University of Oxford, Oxford, UK (O. Pybus)

Main Article

Table 2

Correlates of study participants and human parvovirus 4 infection in multivariate analysis, Cameroon, 2009

Participant characteristic All participants

After exclusions*
Adjusted odds ratio (95% CI) p value Adjusted odds ratio (95% CI) p value
Age group, y
60–64 2.21 (1.13–4.31) 0.02 2.88 (1.16–7.17) 0.02
65–69 1.01 (0.46–2.24) 0.98 1.20 (0.39–3.70) 0.76
70–74 1.16 (0.54–2.46) 0.71 1.51 (0.55–4.16) 0.42
>75 1.00 1.00
Tuberculosis
No 1.00 1.00
Yes, treated with oral drugs only 2.09 (0.58–7.54) 0.26 2.91 (0.63–13.51) 0.17
Yes, treatment included streptomycin 5.21 (0.99–27.37) 0.05 20.96 (1.67–262.99) 0.02
Vaccine scar, left arm
Absent 1.00 1.00
Present 0.37 (0.19–0.71) 0.003 0.32 (0.13–0.78) 0.01
Intravenous treatment for malaria 0.06
No 1.00 1.00
Yes 1.92 (1.13–3.24) 0.015 1.98 (0.97–4.03) 0.06

*After exclusion of 81 participants with borderline negative results and 35 with borderline positive results.

Main Article

Page created: March 15, 2012
Page updated: March 15, 2012
Page reviewed: March 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external